RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 48 filers reported holding RECRO PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $126,000 | -25.0% | 77,335 | -63.4% | 0.00% | – |
| Q2 2022 | $168,000 | -59.5% | 211,536 | -8.3% | 0.00% | – |
| Q1 2022 | $415,000 | +4.0% | 230,664 | -1.2% | 0.00% | – |
| Q4 2021 | $399,000 | -34.5% | 233,408 | -21.1% | 0.00% | -100.0% |
| Q3 2021 | $609,000 | -27.2% | 295,769 | -18.4% | 0.00% | 0.0% |
| Q2 2021 | $837,000 | -24.3% | 362,326 | -8.6% | 0.00% | 0.0% |
| Q1 2021 | $1,106,000 | -49.0% | 396,584 | -47.9% | 0.00% | -50.0% |
| Q4 2020 | $2,169,000 | +25.2% | 761,064 | -7.7% | 0.00% | 0.0% |
| Q3 2020 | $1,732,000 | -38.3% | 824,966 | +33.6% | 0.00% | -33.3% |
| Q2 2020 | $2,809,000 | -21.5% | 617,400 | +41.0% | 0.00% | -50.0% |
| Q1 2020 | $3,577,000 | -39.3% | 437,798 | +36.3% | 0.01% | -14.3% |
| Q4 2019 | $5,889,000 | – | 321,298 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 850,129 | $2,423,000 | 0.65% |
| Newtyn Management, LLC | 700,000 | $1,995,000 | 0.46% |
| Portolan Capital Management | 1,293,376 | $3,686,000 | 0.34% |
| Rubric Capital Management LP | 1,076,587 | $3,068,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,046 | $282,000 | 0.04% |
| Alyeska Investment Group, L.P. | 736,821 | $2,100,000 | 0.03% |
| STEPHENS INC /AR/ | 510,569 | $1,455,000 | 0.03% |
| Clear Harbor Asset Management, LLC | 46,682 | $133,000 | 0.02% |
| WYNNEFIELD CAPITAL INC | 13,000 | $37,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 451,301 | $1,286,000 | 0.01% |